FDA Approved: ACETADOTE — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved Cumberland Pharmaceuticals’ supplemental application for Acetadote (acetylcysteine) under NDA 021539.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acetaminophen Overdose
• Liver Failure

Drugs mentioned

• ACETADOTE (Acetylcysteine)

Snippet

SUPPL AP for ACETADOTE (ACETYLCYSTEINE)